Corgentech and Bristol-Myers Squibb Announce E2F Decoy Trial Results
Corgentech, and Bristol-Myers Squibb Company announced top-line results from PREVENT IV, a Phase 3 clinical trial evaluating the use of…
Part of the
network
network
Tag: corgentech
